| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.3 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.3 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.3 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.3 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |